Drugs known as GLP-1 receptor agonists were initially developed to treat Type 2 diabetes but have become a cultural ...

The drugs reportedly under consideration for coverage include Novo Nordisk's Wegovy and Ozempic, and Eli Lilly's Zepbound and ...

Trump is changing Medicare, mostly focusing on providers. But the biggest impact may come from tariffs and deporting ...

The Trump administration is planning an experiment to cover weight loss drugs under Medicare and Medicaid, potentially ...

Washington Post National Health Reporter Paige Winfield Cunningham discusses how the Trump administration is considering ...

President Trump’s economy reverberated this week amid tariff uncertainty, the weak job report on Friday and the subsequent firing of the Bureau of Labor Statistics (BLS) commissioner, Erika ...

Several companies, including Oracle and Microsoft, are expected to sign pledges to work on the Trump administration ...

Proposed experiment would allow states and Medicare drug plans to cover GLP-1 drugs like Ozempic and Wegovy for obesity, The ...

The Trump administration is considering a five-year pilot program to cover weight-loss drugs under Medicare and Medicaid, the ...

In letters posted on Truth Social, Trump demanded that drugmakers offer their medications at the same prices paid abroad.

Republicans lambasted Democrats last year for subsidizing monthly payments that seniors pay for prescription drug insurance, ...

President Donald Trump on Wednesday made a fresh push to improve Americans’ access to their own medical records, tasking ...